Get started
Author

James O. Newgren

Observed names: J O Newgren, J. Newgren, James Newgren
OpenAlex ID: A5007028126
Inactivation of Human Antithrombin by Neutrophil Elastase
1989 · R E Jordan, R M Nelson, et al. · Journal of Biological Chemistry · 69
Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A mice
2009 · Junliang Pan, Tongyao Liu, et al. · Blood · 44
PDF
Physiology and clinical pathology of laboratory new zealand white rabbits housed individually and in groups.
2008 · Gabriela C Fuentes, James Newgren · PubMed Central · 31
Antithrombin inactivation by neutrophil elastase requires heparin
1989 · Robert E. Jordan, Richard M. Nelson, et al. · The American Journal of Medicine · 13
Preclinical evaluation of alpha-1-proteinase inhibitor
1988 · Michael A. Fournel, James O. Newgren, et al. · The American Journal of Medicine · 13
Site-specific Pegylation of Rfviii Results in Prolonged in Vivo Efficacy
2007 · J.E. Murphy, C. Pan, et al. · Journal of Thrombosis and Haemostasis · 4
Towards a New Therapy for Hemophilia A: Evaluation of Multiple Approaches To Prolong the In Vivo Efficacy of Recombinant Factor VIII.
2006 · John E. Murphy, Clark Pan, et al. · Blood · 3
Evaluation of PEG-FVIII Molecules with Prolonged Half-Lives in a Murine FVIII-Dependent Bleeding Model.
2006 · Kyle A. Landskroner, Zhi-Hua Cui, et al. · Blood · 2
Works count: 8
Citation count: 179
H-index: 5
I10-index: 5
Year
Topic
Type